NRP1 and squamous cell carcinoma: In addition, NRP-1 and HER-2/neu expression have a negative predictive value for overall survival and progression-free survival, respectively, in this population of squamous cell carcinoma of head and neck treated with sorafenib and may predict resistance to this agent, however, further studies are needed.